1. 2004.09-2008.07 浙江大学 本科

2. 2008.09-2013.07 中国科学院上海药物研究所 硕博连读

3. 2013.07-至今 浙江理工大学 教师

1. Fei Ye1, Jie Zhang1, Hongchuan Liu, Rolf Hilgenfeld, Ruihan Zhang, Xiangqian Kong, Lianchun Li, Junyan Lu, Xinlei Zhang, Donghai Li, Hualiang Jiang*, Cai-Guang Yang*, and Cheng Luo*. Helix unfolding/refolding characterizes the functional dynamics of Staphylococcus aureus CLP protease. Journal of Biological Chemistry, 2013, 288(24):17643-17653

2. Baoen Chen1, Fei Ye1, Lu Yu1, Guifang Jia, Xiaotian Huang, Xueju Zhang, Shuying Peng, Kai Chen, Meining Wang, Shouze Gong, Ruihan Zhang, Jinya Yin, Haiyan Li, Yiming Yang, Hong Liu, Jiwen Zhang, Haiyan Zhang, Ao Zhang, Hualiang Jiang, Cheng Luo*, and Cai-Guang Yang*. Development of Cell-active N6-Methyladenosine RNA Demethylase FTO Inhibitor. Journal of the American Chemical Society, 2012, 134(43): 17963–17971.

3. Jie Zhang1, Fei Ye1, Lefu Lan, Hualiang Jiang, Cheng Luo*, Cai-Guang Yang*. Structural Switchings Of Staphylococcus Aureus ClpP: A Key To Understanding Protease Mechanism, Journal of Biological Chemistry, 2011, 286(43): 37590-37601.

4. Fei Ye, Xiangqian Kong, Cheng Luo*. Advance In the Study of Mechanisms regulatd by Sphingosine-1-Phosphate, Bulletin of National Natural Science Foundation of China, 2010, 18(1), 57-60.

5. 叶飞，孔祥谦，罗成*，鞘氨磷酸脂调控机制的研究进展，中国科学基金，2010, 24(5), 279-282.

6. 专利：大黄酸或大黄酸类化合物在制备治疗以FTO为靶点的疾病的药物中的用途；专利号：201210197108；公开日：2012.10.03；申请（专利权）人：中国科学院上海药物研究所；发明（设计）人：杨财广、罗成、叶飞、陈报恩、俞璐、蒋华良